Vendor Intelligence Report: Zhengzhou Lan Yun Cosmetic Trading

Published 2 Jul 2026. 17-page investigative report on who is behind Zhengzhou Lan Yun Cosmetic Trading: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Across 20 Finnrick lab tests, Zhengzhou Lan Yun Cosmetic Trading posts an 18-pass/2-fail record, an overall pass rate of 90%. The record is product-specific rather than blanket reassurance: GHK-Cu and Tirzepatide look like the stronger tested choices, while Retatrutide carries the failures and enough batch movement to justify current COA review or independent re-testing. The full report shows how stricter scoring changes the read where fill accuracy matters.

The identity trail is more complicated. Chinese corporate records support an older Zhengzhou trading entity, but WHOIS and Wayback captures show a much newer English-language peptide storefront. Website wording, a Hong Kong contact signal on a mainland-China profile, and the absence of named founders or lab staff leave the buyer with a real counterparty but limited human accountability.

The investigation also treats Zhengzhou Strong Peptide as a network-level signal: the parallel storefront shares Zhengzhou positioning and an identical catalog pattern while using different regional contacts. A BBB Scam Tracker complaint against that parallel site alleges false shipping activity involving ShipZone Logistics; it is not attributed directly to Lanyun, but it makes payment timing, carrier proof, and surprise-fee refusal central. Site review also found steroid or controlled-drug-adjacent inventory beside peptides, while the public affiliate scan found no coupon-driven promotion apparatus.

Inside the full report:

  • Per-product pass/fail rates, rating trajectories, and methodology-divergence charts for all 3 tested products
  • QCC corporate-record analysis for the registered Zhengzhou entity and legal representative
  • WHOIS, Hosting Checker, and Wayback exhibits for zhengzhoulanyun.com
  • Parallel-storefront comparison with Zhengzhou Strong Peptide and the BBB/ShipZone complaint trail
  • Affiliate-scan results across X, web coupon searches, and Reddit coverage gaps
  • Buyer verification checklist covering canonical domain, batch COAs, carrier changes, and logistics fees

Risk assessment

  • Fulfillment and sister-brand shipping-fraud allegation risk — high: BBB Scam Tracker complaint #1129105 names Zhengzhou Strong Peptide, an evidence-linked parallel storefront; no direct BBB complaint was found for Lanyun.
  • Corporate-identity and brand-confusion risk — medium: Website branding differs from the QCC-identified registered entity, uses a Hong Kong phone despite mainland claims, and no official channel or reseller list was found.
  • Product-specific quality inconsistency — Retatrutide — medium: Retatrutide is Lanyun’s weakest tested line at 78.93% across 9 tests (7 pass / 2 fail), below Tirzepatide at 85.57% and GHK-Cu at 91.5%.
  • Mixed controlled-substance catalog risk — medium: Site review found research peptides sold alongside anabolic-steroid or controlled-drug-adjacent items such as Methandrostenolone and Clenbuterol.